Autologous Transplantation in Breast Cancer in Europe and EBMT Data

Breast carcinoma is still in the new milnennium a formidable challenge as for physicians and as for patients. Despite clear progress in early diagnosis and novel therapeutic strategies, still much has to be done as far as metastatic disease (which is an ultimately fatal disease for more than 95% of the patients) and high-risk or very high-risk operable carcinoma (i.e. patients with multiple axillary nodes).